New eye injection aims to stretch time between treatments for leading cause of vision loss

This study tested whether a new type of eye injection called faricimab could help people with 'wet' age-related macular degeneration (AMD) go longer between treatments. Researchers gave 742 older adults three monthly loading injections and then monitored how many weeks passed before they needed another shot. The goal was to see if this approach could effectively control the disease while reducing the burden of frequent clinic visits and injections.